Kristi A Sacco

Summary

Affiliation: Yale University
Country: USA

Publications

  1. pmc Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
    Kristi A Sacco
    Program for Research in Smokers with Mental Illness, Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA
    J Psychopharmacol 18:457-74. 2004
  2. ncbi request reprint Neuropsychological deficits in nonsmokers with schizophrenia: effects of a nicotinic antagonist
    Kristi A Sacco
    Program for Research in Smokers with Mental Illness PRISM, Yale University School of Medicine, New Haven, CT 06519, USA
    Schizophr Res 85:213-21. 2006
  3. ncbi request reprint Adverse childhood experiences, smoking and mental illness in adulthood: a preliminary study
    Kristi A Sacco
    Program for Research in Smokers with Mental Illness PRISM, Connecticut Mental Health Center, Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    Ann Clin Psychiatry 19:89-97. 2007
  4. ncbi request reprint Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms
    Kristi A Sacco
    Program for Research in Smokers with Mental Illness, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    Arch Gen Psychiatry 62:649-59. 2005
  5. pmc Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia
    Andrea H Weinberger
    Program for Research on Smokers with Mental Illness PRISM, Yale University School of Medicine, Department of Psychiatry, 34 Park Street, New Haven, CT 06519, USA
    Schizophr Res 91:217-25. 2007
  6. ncbi request reprint Reliability of the Fagerström Test for Nicotine Dependence, Minnesota Nicotine Withdrawal Scale, and Tiffany Questionnaire for Smoking Urges in smokers with and without schizophrenia
    Andrea H Weinberger
    Program for Research on Smokers with Mental Illness, Yale University School of Medicine, New Haven, CT 06511, USA
    Drug Alcohol Depend 86:278-82. 2007
  7. ncbi request reprint Smoking cue reactivity in schizophrenia: effects of a nicotinic receptor antagonist
    Margaret A Fonder
    Program for Research in Smokers with Mental Illness PRISM, Connecticut Mental Health Center, and Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    Biol Psychiatry 57:802-8. 2005
  8. ncbi request reprint A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms
    Tony P George
    Program for Research in Smokers with Mental Illness PRISM, Department of Psychiatry, Yale University School of Medicine, Substance Abuse Center, Connecticut Mental Health Center, New Haven, CT 06519, USA
    Schizophr Res 87:307-15. 2006
  9. ncbi request reprint Neuropsychological deficits are associated with smoking cessation treatment failure in patients with schizophrenia
    Sara L Dolan
    Department of Psychiatry, Yale University School of Medicine, Connecticut Mental Health Center, 34 Park Street, Rm S 109, Substance Abuse Center, New Haven, CT 06519, USA
    Schizophr Res 70:263-75. 2004
  10. ncbi request reprint Neurocognitive performance among alcohol dependent men with and without physical violence toward their partners: a preliminary report
    Caroline J Easton
    Department of Psychiatry, Division of Substance Abuse, Yale University School of Medicine SATU, New Haven, Connecticut 06511, USA
    Am J Drug Alcohol Abuse 34:29-37. 2008

Detail Information

Publications14

  1. pmc Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
    Kristi A Sacco
    Program for Research in Smokers with Mental Illness, Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA
    J Psychopharmacol 18:457-74. 2004
    ..The potential benefits of nicotinic agents for therapeutic use in neuropsychiatric disorders is discussed, as well as directions for further research in this area...
  2. ncbi request reprint Neuropsychological deficits in nonsmokers with schizophrenia: effects of a nicotinic antagonist
    Kristi A Sacco
    Program for Research in Smokers with Mental Illness PRISM, Yale University School of Medicine, New Haven, CT 06519, USA
    Schizophr Res 85:213-21. 2006
    ....
  3. ncbi request reprint Adverse childhood experiences, smoking and mental illness in adulthood: a preliminary study
    Kristi A Sacco
    Program for Research in Smokers with Mental Illness PRISM, Connecticut Mental Health Center, Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    Ann Clin Psychiatry 19:89-97. 2007
    ..This study was designed to examine effects of ACE on the expression of smoking behavior and mental illness in adulthood...
  4. ncbi request reprint Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms
    Kristi A Sacco
    Program for Research in Smokers with Mental Illness, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    Arch Gen Psychiatry 62:649-59. 2005
    ..Cigarette smoking rates in schizophrenia are higher than in the general population...
  5. pmc Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia
    Andrea H Weinberger
    Program for Research on Smokers with Mental Illness PRISM, Yale University School of Medicine, Department of Psychiatry, 34 Park Street, New Haven, CT 06519, USA
    Schizophr Res 91:217-25. 2007
    ....
  6. ncbi request reprint Reliability of the Fagerström Test for Nicotine Dependence, Minnesota Nicotine Withdrawal Scale, and Tiffany Questionnaire for Smoking Urges in smokers with and without schizophrenia
    Andrea H Weinberger
    Program for Research on Smokers with Mental Illness, Yale University School of Medicine, New Haven, CT 06511, USA
    Drug Alcohol Depend 86:278-82. 2007
    ..65 versus 0.79), and TQSU Factor 2 (0.69 versus 0.81), but did not differ between diagnostic groups for M-NWS (0.58 versus 0.64). Our findings suggest that these measures may be reliable for use in smokers with schizophrenia...
  7. ncbi request reprint Smoking cue reactivity in schizophrenia: effects of a nicotinic receptor antagonist
    Margaret A Fonder
    Program for Research in Smokers with Mental Illness PRISM, Connecticut Mental Health Center, and Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    Biol Psychiatry 57:802-8. 2005
    ....
  8. ncbi request reprint A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms
    Tony P George
    Program for Research in Smokers with Mental Illness PRISM, Department of Psychiatry, Yale University School of Medicine, Substance Abuse Center, Connecticut Mental Health Center, New Haven, CT 06519, USA
    Schizophr Res 87:307-15. 2006
    ..We evaluated the effects of cigarette smoking on PPI deficits in schizophrenia, and the role of nicotinic acetylcholine receptors (nAChRs) in mediating cigarette smoking-related PPI enhancement...
  9. ncbi request reprint Neuropsychological deficits are associated with smoking cessation treatment failure in patients with schizophrenia
    Sara L Dolan
    Department of Psychiatry, Yale University School of Medicine, Connecticut Mental Health Center, 34 Park Street, Rm S 109, Substance Abuse Center, New Haven, CT 06519, USA
    Schizophr Res 70:263-75. 2004
    ..These preliminary data suggest that in schizophrenics, neuropsychological deficits are associated with smoking cessation treatment failure...
  10. ncbi request reprint Neurocognitive performance among alcohol dependent men with and without physical violence toward their partners: a preliminary report
    Caroline J Easton
    Department of Psychiatry, Division of Substance Abuse, Yale University School of Medicine SATU, New Haven, Connecticut 06511, USA
    Am J Drug Alcohol Abuse 34:29-37. 2008
    ..The authors examined neurocognitive performance among treatment-seeking alcohol dependent men with (IPV+) and without reported physical violence (IPV-)...
  11. doi request reprint Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study
    Tony P George
    Division of Substance Abuse, Department of Psychiatry, Program for Research in Smokers with Mental Illness, Yale University School of Medicine, New Haven, CT, USA
    J Clin Psychopharmacol 28:340-4. 2008
    ..We compared the nicotinic antagonist, mecamylamine hydrochloride (MEC), with placebo as an augmentation strategy for patients with MDD who were refractory to selective serotonin reuptake inhibitor (SSRI) treatment...
  12. pmc Risk/reward decision-making in schizophrenia: a preliminary examination of the influence of tobacco smoking and relationship to Wisconsin Card Sorting Task performance
    Sarah W Yip
    Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, Connecticut Mental Health Center, 2 Church Street South, Suite 215, New Haven, CT, United States
    Schizophr Res 110:156-64. 2009
    ..Studies of risk/reward decision-making in individuals with schizophrenia have yielded mixed results, and few studies have examined systematically the relationship between these domains and their relationship with clinical factors...
  13. pmc A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia
    Tony P George
    Centre for Addiction and Mental Health, Faculty of Medicine, University of Toronto, Ontario, Canada
    Biol Psychiatry 63:1092-6. 2008
    ..We determined whether the combination of sustained-release (SR) bupropion (BUP) with the transdermal nicotine patch (TNP) was well-tolerated and superior to placebo (PLO)+TNP for smoking cessation in schizophrenia...
  14. doi request reprint Effects of galantamine on cognitive deficits in smokers and non-smokers with schizophrenia
    Kristi A Sacco
    Schizophr Res 103:326-7. 2008